Vitamin D and its role in skeletal muscle

Calcified Tissue International

Volumn 92, Issue 2, 2013, Pages 151-162

  Ceglia, Lisa ^a,b   Harris, Susan S ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Skeletal muscle; Vitamin D; Vitamin D receptor

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; OXYGENASE; PHOSPHATE; PLACEBO; VITAMIN D; VITAMIN D RECEPTOR;

ACCIDENT PREVENTION; CALCIUM METABOLISM; CELL PROLIFERATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CYP27B1 GENE; FALLING; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GRIP STRENGTH; HISTOPATHOLOGY; HUMAN; KNOCKOUT MOUSE; MULTICENTER STUDY (TOPIC); MUSCLE CONTRACTILITY; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; OBSERVATIONAL STUDY; OSTEOMALACIA; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR UPREGULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; TREATMENT DURATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84873732482     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9645-y     Document Type: Review

References (129)

1. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80:1689S-1696S
2. Reichel H, Koeffler HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. New Engl J Med 320:980-991
3. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764
4. Bikle DD (2010) Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 21:375-384
5. Boland R (1986) Role of vitamin D in skeletal muscle function. Endocr Rev 7:434-448
6. Visser M, Deeg DJ, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88:5766-5772
7. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980-2985
8. Schubert L, DeLuca HF (2010) Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500:157-161
9. 3 receptors and activities in muscle. J Biol Chem 260:8882-8891
10. 3 receptor in human skeletal muscle tissue. Histochem J 33:19-24
11. Dent CE, Richens A, Rowe DJ, Stamp TC (1970) Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J 4:69-72
12. Smith R, Stern G (1967) Myopathy, osteomalacia and hyperparathyroidism. Brain 90:593-602
13. Prineas JW, Mason AS, Henson RA (1965) Myopathy in metabolic bone disease. Br Med J 1:1034-1036
14. Marsden CD, Reynolds EH, Parsons V, Harris R, Duchen L (1973) Myopathy associated with anticonvulsant osteomalacia. Br Med J 4:526-527
15. Smith R, Stern G (1969) Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 8:511-520
16. Wassner SJ, Li JB, Sperduto A, Norman ME (1983) Vitamin D deficiency, hypocalcemia, and increased skeletal muscle degradation in rats. J Clin Invest 72:102-112
17. Gloth FM 3rd, Tobin JD, Sherman SS, Hollis BW (1991) Is the recommended daily allowance for vitamin D too low for the homebound elderly? J Am Geriatr Soc 39:137-141
18. Schott GD, Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1(7960):626-629
19. Skaria J, Katiyar BC, Srivastava TP, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37-58
20. Yoshikawa S, Nakamura T, Tanabe H, Imamura T (1979) Osteomalacic myopathy. Endocrinol Jpn 26:65-72
21. Palmucci L, Bertolotto A, Doriguzzi C, Mongini T, Coda R (1982) Osteomalacic myopathy in a case of diffuse nodular lipomatosis of the small bowel. Acta Neurol Belgica 82:65-71
22. McComas A (1996) Skeletal muscle. Form and function. Human Kinetics Publishers, Champaign
23. Gilsanz V, Kremer A, Mo AO, Wren TA, Kremer R (2010) Vitamin D status and its relation to muscle mass and muscle fat in young women. J Clin Endocrinol Metab 95:1595-1601
24. Lazaro RP, Kirshner HS (1980) Proximal muscle weakness in uremia. Case reports and review of the literature. Arch Neurol 37:555-558
25. Floyd M, Ayyar DR, Barwick DD, Hudgson P, Weightman D (1974) Myopathy in chronic renal failure. Q J Med 43:509-524
26. Tague SE, Clarke GL, Winter MK, McCarson KE, Wright DE, Smith PG (2011) Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. J Neurosci 31:13728-13738
27. Sorensen OH, Lund B, Saltin B, Lund B, Andersen RB, Hjorth L, Melsen F, Mosekilde L (1979) Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) 56:157-161
28. Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 20:187-192
29. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, Dawson-Hughes B (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 80:752-758
30. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P (2007) Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92:2058-2065
31. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94:1244-1250
32. Houston DK, Tooze JA, Davis CC, Chaves PH, Hirsch CH, Robbins JA, Arnold AM, Newman AB, Kritchevsky SB (2011) Serum 25-hydroxyvitamin D and physical function in older adults: the Cardiovascular Health Study All Stars. J Am Geriatr Soc 59:1793-1801
33. Chan R, Chan D, Woo J, Ohlsson C, Mellstrom D, Kwok T, Leung PC (2012) Not all elderly people benefit from vitamin D supplementation with respect to physical function: results from the Osteoporotic Fractures in Men Study, Hong Kong. J Am Geriatr Soc 60:290-295
34. Ceglia L, Chiu GR, Harris SS, Araujo AB (2011) Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clin Endocrinol (Oxf) 74:370-376
35. Ward KA, Das G, Berry JL, Roberts SA, Rawer R, Adams JE, Mughal Z (2009) Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab 94:559-563
36. Foo LH, Zhang Q, Zhu K, Ma G, Hu X, Greenfield H, Fraser DR (2009) Low vitamin D status has an adverse influence on bone mass, bone turnover, and muscle strength in Chinese adolescent girls. J Nutr 139:1002-1007
37. Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, Bahiri R, Abouqal R, Hajjaj-Hassouni N (2009) High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum 38:444-451
38. Garnero P, Munoz F, Sornay-Rendu E, Delmas PD (2007) Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 40:716-722
39. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20:315-322
40. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113-1118
41. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelmann M (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-351
42. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, Allain TJ (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33:589-595
43. Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA (2003) Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 51:1762-1767
44. Latham NK, Anderson CS, Lee A, Bennett DA, Moseley A, Cameron ID (2003) A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 51:291-299
45. Brunner RL, Cochrane B, Jackson RD, Larson J, Lewis C, Limacher M, Rosal M, Shumaker S, Wallace R (2008) Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative. J Am Diet Assoc 108:1472-1479
46. Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, Chandler J, Rosenberg E, Papanicolaou DA (2010) Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr 91:985-991
47. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22:859-871
48. Muir SW, Montero-Odasso M (2011) Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 59:2291-2300
49. 3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 17:1318-1328
50. Suzuki T, Kwon J, Kim H, Shimada H, Yoshida Y, Iwasa H, Yoshida H (2008) Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly. J Bone Miner Res 23:1309-1317
51. Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, Thomasx J, Hopper JL, Wark JD (2003) Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 51:1533-1538
52. Stein MS, Wark JD, Scherer SC, Walton SL, Chick P, Di Carlantonio M, Zajac JD, Flicker L (1999) Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 47:1195-1201
53. Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SH, Swift CG, Allain TJ (2002) Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17:891-897
54. Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R (2010) Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 153:815-825
55. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, Almandoz JP, Mullan RJ, Lane MA, Liu H, Erwin PJ, Hensrud DD, Montori VM (2011) Clinical review. The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997-3006
56. Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH (2009) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev (2):CD007146
57. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53-58
58. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ (Clin Res Ed) 339:b3692
59. Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC, Can U, Egli A, Mueller NJ, Looser S, Bretscher B, Minder E, Vergopoulos A, Theiler R (2010) Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 170:813-820
60. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815-1822
61. Rodman JS, Baker T (1978) Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int 13:189-193
62. Curry OB, Basten JF, Francis MJ, Smith R (1974) Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits. Nature 249:83-84
63. Matthews C, Heimberg KW, Ritz E, Agostini B, Fritzsche J, Hasselbach W (1977) Effect of 1,25-dihydroxycholecalciferol on impaired calcium transport by the sarcoplasmic reticulum in experimental uremia. Kidney Int 11:227-235
64. Birge SJ, Haddad JG (1975) 25-Hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56:1100-1107
65. 3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119:2214-2220
66. Ceglia L, da Silva Morais M, Park LK, Morris E, Harris SS, Bischoff-Ferrari HA, Fielding RA, Dawson-Hughes B (2010) Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol 41:137-142
67. Srikuea R, Zhang X, Park-Sarge OK, Esser KA (2012) VDR and CYP27B1 are expressed in c2c12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 303:C396-C405
68. Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8-F28
69. 3 receptors: structure and function in transcription. Annu Rev Nutr 11:189-216
70. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW (1988) Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298
71. McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW (1987) Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235:1214-1217
72. DeLuca HF (1988) The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 2:224-236
73. Haussler MR, Mangelsdorf DJ, Komm BS, Terpening CM, Yamaoka K, Allegretto EA, Baker AR, Shine J, McDonnell DP, Hughes M et al (1988) Molecular biology of the vitamin D hormone. Recent Prog Horm Res 44:263-305
74. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229
75. Nemere I, Farach-Carson MC (1998) Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem Biophys Res Commun 248:443-449
76. Baran DT, Quail JM, Ray R, Leszyk J, Honeyman T (2000) Annexin II is the membrane receptor that mediates the rapid actions of 1alpha,25-dihydroxyvitamin D(3). J Cell Biochem 78:34-46
77. 3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 86:128-135
78. Buitrago C, Boland R (2010) Caveolae and caveolin-1 are implicated in 1alpha,25(OH)(2)-vitamin D(3)-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. J Steroid Biochem Mol Biol 121:169-175
79. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39
80. Galbiati F, Razani B, Lisanti MP (2001) Emerging themes in lipid rafts and caveolae. Cell 106:403-411
81. 3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun 128:305-311
82. Wang Y, DeLuca HF (2011) Is the vitamin D receptor found in muscle? Endocrinology 152:354-363
83. Ceglia LMM, Park L, Harris S, Bischoff-Ferrari H, Fielding RA, Dawson-Hughes B (2008) Immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle fibers. Osteoporos Int 19(suppl 2):S418
84. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138-5144
85. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157:299-308
86. 2 and calbindin D9k mRNA. J Nutr 133:374-380
87. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P (2004) Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res Bull 64:25-29
88. Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, Syvala H, Lou YR, Kalueff AV, Pyykko I, Tuohimaa P (2009) Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 114:161-166
89. 3. Mol Cell Endocrinol 114:1-8
90. Ebashi S, Endo M (1968) Calcium ion and muscle contraction. Prog Biophys Mol Biol 18:123-183
91. 3. Biochem Mol Biol Int 32:859-867
92. Drittanti LN, Boland RL, de Boland AR (1989) Induction of specific proteins in cultured skeletal muscle cells by 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1012:16-23
93. Zanello SB, Boland RL, Norman AW (1995) cDNA sequence identity of a vitamin D-dependent calcium-binding protein in the chick to calbindin D-9K. Endocrinology 136:2784-2787
94. 3 affects the synthesis, phosphorylation and in vitro calmodulin binding of myoblast cytoskeletal proteins. Z Naturforsch C 45:1156-1160
95. 3. Mol Cell Endocrinol 74:143-153
96. 3 on phosphate accumulation by myoblasts. Horm Metab Res 23:113-116
97. Inoue Y, Segawa H, Kaneko I, Yamanaka S, Kusano K, Kawakami E, Furutani J, Ito M, Kuwahata M, Saito H, Fukushima N, Kato S, Kanayama HO, Miyamoto K (2005) Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 390:325-331
98. 3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro. Calcif Tissue Int 36:200-205
99. Drittanti L, de Boland AR, Boland R (1989) Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1014:112-119
100. 3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152:2976-2986
101. Dirks-Naylor AJ, Lennon-Edwards S (2011) The effects of vitamin D on skeletal muscle function and cellular signaling. J Steroid Biochem Mol Biol 125:159-168
102. Williams TM, Lisanti MP (2004) The Caveolin genes: from cell biology to medicine. Ann Med 36:584-595
103. Buitrago C, Arango N, Boland R (2012) 1alpha,25(OH)(2)D(3)-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. J Cell Biochem 113:1170-1181
104. 3-induced anti-apoptotic PI3K/AKT signaling in osteoblasts. J Bone Miner Res 23:1238-1248
105. 3. Mol Cell Endocrinol 77:67-73
106. 3 are suppressed by calcium channel blockers. Endocrinology 120:1858-1864
107. 3 stimulation of phospholipases C and D in muscle cells involves extracellular calcium and a pertussis-sensitive G protein. Mol Cell Endocrinol 122:207-211
108. 3 of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. Biochim Biophys Acta 1269:91-97
109. Capiati DA, Vazquez G, Tellez Inon MT, Boland RL (2000) Role of protein kinase C in 1,25(OH)(2)-vitamin D(3) modulation of intracellular calcium during development of skeletal muscle cells in culture. J Cell Biochem 77:200-212
110. 3 stimulates the adenylyl cyclase pathway in muscle cells by a GTP-dependent mechanism which presumably involves phosphorylation of G alpha i. Biochem Biophys Res Commun 234:125-128
111. 2+ uptake in rat and chick cultured myoblasts. Biochim Biophys Acta 1310:157-162
112. 2+ entry in skeletal muscle cells. Biochem Biophys Res Commun 239:562-565
113. 2+ influx in skeletal muscle cells. Modulation by phospholipase c, protein kinase c, and tyrosine kinases. J Biol Chem 273:33954-33960
114. 3. Biochem Mol Biol Int 31:677-684
115. Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, Walker NM, Lam AC, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Newport MJ, Clayton DG, Todd JA (2004) Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 13:1633-1639
116. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12:915-921
117. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145-159
118. Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE (2004) Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol 59:10-15
119. Windelinckx A, De Mars G, Beunen G, Aerssens J, Delecluse C, Lefevre J, Thomis MA (2007) Polymorphisms in the vitamin D receptor gene are associated with muscle strength in men and women. Osteoporos Int 18:1235-1242
120. Hopkinson NS, Li KW, Kehoe A, Humphries SE, Roughton M, Moxham J, Montgomery H, Polkey MI (2008) Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 87:385-390
121. Geusens P, Vandevyver C, Vanhoof J, Cassiman JJ, Boonen S, Raus J (1997) Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J Bone Miner Res 12:2082-2088
122. Onder G, Capoluongo E, Danese P, Settanni S, Russo A, Concolino P, Bernabei R, Landi F (2008) Vitamin D receptor polymorphisms and falls among older adults living in the community: results from the ilSIRENTE study. J Bone Miner Res 23:1031-1036
123. Barr R, Macdonald H, Stewart A, McGuigan F, Rogers A, Eastell R, Felsenberg D, Gluer C, Roux C, Reid DM (2010) Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int 21:457-466
124. Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A (2004) Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol 150:323-328
125. Bahat G, Saka B, Erten N, Ozbek U, Coskunpinar E, Yildiz S, Sahinkaya T, Karan MA (2010) BsmI polymorphism in the vitamin D receptor gene is associated with leg extensor muscle strength in elderly men. Aging Clin Exp Res 22:198-205
126. Zehnder D, Bland R, Walker EA, Bradwell AR, Howie AJ, Hewison M, Stewart PM (1999) Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465-2473
127. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91-100
128. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888-894
129. Lou YR, Molnar F, Perakyla M, Qiao S, Kalueff AV, St-Arnaud R, Carlberg C, Tuohimaa P (2010) 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 118:162-170